Statement, October 2020
PROPOSAL BY INDIA AND SOUTH AFRICA TO WAIVE CERTAIN PROVISIONS OF THE WTO TRIPS AGREEMENT TO SUPPORT THE GLOBAL COVID-19 PANDEMIC RESPONSE
The prolongation of the coronavirus COVID-19 pandemic threatens developing countries disproportionately, deepening the catastrophic social and economic crisis and reversing the gains made to date to eradicate extreme poverty and meet the Sustainable Development Goals (SDGs). In this situation, ensuring timely access to essential commodities by overcoming acute shortages faced by countries due to high demand and disruptions in the supply chain is critical. There is also an urgent need to speed up development of new vaccines, treatments and diagnostics, at scale, and make these widely available.
As reaffirmed by many delegations in the special session of the WHO Executive Board, transfer of technology and know-how is fundamental for scaling up manufacturing of medical products and equipment. In this regard, India and South Africa have made a joint proposal to the World Trade Organization (WTO) to temporarily waive certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to support the global Covid-19 pandemic response.
Download Statement below:
This article was tagged: Access to COVID-19 Tools (Accelerator) - (ACT), Access to Medicines, Article 73 TRIPS, Compulsory Licenses, Coronavirus, COVID-19, Diagnostics, Doha Declaration on the TRIPS Agreement and Public Health, Flexibilities, Global Health, Health, Human Rights, India, Innovation, Intellectual Property, Pandemic, Patent, Public Health, Research and Development (R&D), Right to Health, South Africa, TRIPS, TRIPS Council, TRIPS Waiver, Vaccines, WHO Executive Board (EB), World Trade Organization (WTO)
